Clinical Trials Browser

Stomach Neoplasms × CA-4948 × 90 days × Clear all

NCT05187182 2026-04-27

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

Phase 1 Recruiting

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms